Pharmaceutical packaging is evolving in response to growing product complexity, extended global supply chains, and increasing expectations around quality and patient safety. Today, packaging must do more than simply contain a drug product. It must actively protect it throughout its entire lifecycle. As degradation and impurities risks become more difficult to manage through formulation and process controls alone, pharmaceutical manufacturers are increasingly looking to packaging as a critical part of their overall risk mitigation strategy. Advanced packaging solutions can help maintain drug stability, preserve quality, and support regulatory compliance from manufacturing through patient use.

This industry shift from traditional containment toward active protection was recently explored in Pharmaceutical Technology, a leading global publication serving the pharmaceutical industry.

In the article “The Shift from Containment to Protection: Packaging Trends Impacting Pharma,” Badre Hammond, our VP Global Commercial Operations and GM, APAC shares insights on how packaging innovation is helping pharmaceutical manufacturers address today’s challenges. The written Q&A examines:
• Why containment focused packaging is no longer sufficient for many modern drug products.
• How protective packaging technologies help manage impurities and degradation risks.
• The growing role of packaging in supporting product performance, quality, and patient safety.

The article also highlights how packaging is becoming a performance enabling component of the pharmaceutical value chain, working in tandem with formulation and manufacturing strategies to protect product integrity. Click here to read the full article.